943 related articles for article (PubMed ID: 11255443)
1. Mild cognitive impairment represents early-stage Alzheimer disease.
Morris JC; Storandt M; Miller JP; McKeel DW; Price JL; Rubin EH; Berg L
Arch Neurol; 2001 Mar; 58(3):397-405. PubMed ID: 11255443
[TBL] [Abstract][Full Text] [Related]
2. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI.
Storandt M; Grant EA; Miller JP; Morris JC
Neurology; 2006 Aug; 67(3):467-73. PubMed ID: 16894109
[TBL] [Abstract][Full Text] [Related]
4. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
6. Rates of progression in mild cognitive impairment and early Alzheimer's disease.
Storandt M; Grant EA; Miller JP; Morris JC
Neurology; 2002 Oct; 59(7):1034-41. PubMed ID: 12370458
[TBL] [Abstract][Full Text] [Related]
7. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
Morris JC; Roe CM; Grant EA; Head D; Storandt M; Goate AM; Fagan AM; Holtzman DM; Mintun MA
Arch Neurol; 2009 Dec; 66(12):1469-75. PubMed ID: 20008650
[TBL] [Abstract][Full Text] [Related]
8. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
Dickerson BC; Sperling RA; Hyman BT; Albert MS; Blacker D
Arch Gen Psychiatry; 2007 Dec; 64(12):1443-50. PubMed ID: 18056553
[TBL] [Abstract][Full Text] [Related]
9. Impaired physical performance and the assessment of dementia of the Alzheimer type.
Shah KR; Carr D; Roe CM; Miller JP; Coats M; Morris JC
Alzheimer Dis Assoc Disord; 2004; 18(3):112-9. PubMed ID: 15494615
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of motor vehicle crashes of drivers with dementia of the Alzheimer type.
Carr DB; Duchek J; Morris JC
J Am Geriatr Soc; 2000 Jan; 48(1):18-22. PubMed ID: 10642016
[TBL] [Abstract][Full Text] [Related]
11. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
[TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of a Reaction-Time Attention Task in the Evaluation of Cognitive Impairment in Elderly with High Educational Disparity.
Schmidt SL; Boechat YEM; Schmidt GJ; Nicaretta D; van Duinkerken E; Schmidt JJ
J Alzheimers Dis; 2021; 81(2):691-697. PubMed ID: 33814451
[TBL] [Abstract][Full Text] [Related]
13. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal driving performance in early-stage dementia of the Alzheimer type.
Duchek JM; Carr DB; Hunt L; Roe CM; Xiong C; Shah K; Morris JC
J Am Geriatr Soc; 2003 Oct; 51(10):1342-7. PubMed ID: 14511152
[TBL] [Abstract][Full Text] [Related]
15. Progression of mild cognitive impairment to Alzheimer's or vascular dementia versus normative aging among elderly Chinese.
Huang J; Meyer JS; Zhang Z; Wei J; Hong X; Wang J; Wen H; Wu W; Wu J; Chowdhury MH
Curr Alzheimer Res; 2005 Dec; 2(5):571-8. PubMed ID: 16375660
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
Purohit DP; Perl DP; Haroutunian V; Powchik P; Davidson M; Davis KL
Arch Gen Psychiatry; 1998 Mar; 55(3):205-11. PubMed ID: 9510214
[TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.
Bozoki A; Giordani B; Heidebrink JL; Berent S; Foster NL
Arch Neurol; 2001 Mar; 58(3):411-6. PubMed ID: 11255444
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of mild cognitive impairment by definition: a population study.
Ganguli M; Snitz BE; Saxton JA; Chang CC; Lee CW; Vander Bilt J; Hughes TF; Loewenstein DA; Unverzagt FW; Petersen RC
Arch Neurol; 2011 Jun; 68(6):761-7. PubMed ID: 21670400
[TBL] [Abstract][Full Text] [Related]
19. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
Bakkour A; Morris JC; Dickerson BC
Neurology; 2009 Mar; 72(12):1048-55. PubMed ID: 19109536
[TBL] [Abstract][Full Text] [Related]
20. MRI abnormalities associated with mild cognitive impairments of vascular (VMCI) versus neurodegenerative (NMCI) types prodromal for vascular and Alzheimer's dementias.
Meyer JS; Huang J; Chowdhury M
Curr Alzheimer Res; 2005 Dec; 2(5):579-85. PubMed ID: 16375661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
